細胞表面標誌物市場：按產品類型、應用和地區分類

Cell Surface Markers Market, By Product Type, By Application, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，細胞表面標誌物市場規模將達到 409.3 億美元，到 2033 年將達到 738.7 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	409.3億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.80%	2033年市場規模預測：	738.7億美元

細胞表面標誌物是表達於細胞表面的特化蛋白質，或是與細胞膜結合的碳水化合物，通常被方便地用作特定細胞類型的標誌。雖然有些蛋白質負責跨膜運輸分子，但細胞表面標誌物在細胞間通訊和識別中發揮著至關重要的作用。細胞表面標誌物可用於根據其特徵對細胞進行分類。這些數據可用於識別各種類型的細胞，從癌細胞到幹細胞，甚至包括HIV感染細胞。簡而言之，細胞表面標誌物就像指紋一樣，每種細胞類型都具有獨特的特徵，並且可以透過細胞膜上的標記物來識別。目前，最常見的細胞表面標誌物是CD抗原，也稱為CD分子（分化叢集）。 CD分子對於識別白血球非常有用，但它們不僅僅是細胞表面標記。目前已知的CD分子中只有一小部分得到了詳細的闡明，但大多數都具有重要的功能。除了簡單的細胞辨識之外，細胞表面標誌物還有潛力促進藥物研發，尤其是在支持個人化醫療方面。根據表面標誌物識別單一細胞的能力，正在為科學家帶來新藥研發的突破性進展。

市場動態

預計新產品發布以及主要市場參與者併購的增加將推動全球細胞表面標誌物市場的成長。例如，2021年1月13日，總部位於美國的跨國醫療技術公司貝克頓·迪金森公司（Becton, Dickinson and Company）宣布正式推出BD AbSeq免疫發現試劑盒（IDP）。該試劑盒是一種先進的預稀釋抗體寡核苷酸發現工具，可在單次實驗中檢測30種不同的免疫標記。 BD AbSeq IDP基於BD AbSeq檢測技術的進步，該技術利用次世代定序在單細胞層級分析蛋白質表現。 BD AbSeq IDP是一款便捷、可靠且柔軟性的多體學學工具，能夠為免疫學研究和藥物發現提供支援。 BD AbSeq IDP 是基於 BD 的抗體寡核苷酸技術開發，包含 30 種針對大多數主要免疫標記的特異性抗體，並封裝在單一試劑盒中。此試劑盒可用於鑑定免疫細胞類型。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球細胞表面標誌物市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球細胞表面標誌物市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球細胞表面標誌物市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Abbott Laboratories, Inc.
Beckman Coulter, Inc.
BD Biosciences
Bio-Rad Laboratories, Inc.
Grifols SA
Immucor, Inc.
Janssen Diagnostics, Inc.
Nihon Kohden Corporation
Hoffmann-La Roche Ltd.
Siemens Healthcare
Sysmex Corporation
Thermo Fisher Scientific, Inc.

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI3912

Cell Surface Markers Market is estimated to be valued at USD 40.93 Bn in 2026 and is expected to reach USD 73.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 40.93 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.80%	2033 Value Projection:	USD 73.87 Bn

Cell surface markers are special proteins expressed on the surface of cells or carbohydrates attached to the cell membrane that often conveniently serve as markers of specific cell types. While some proteins have the task of allowing the transport of molecules across the membrane, cell surface markers play a role in inter-cellular communication and recognition. Cell surface markers are used to classify cells according to its markers. This data, in turn, is used to identify different kinds of cells, from cancer cells to stem cells to cells infected with HIV. In short, cell surface markers are like a fingerprint, specific to each kind of cell, and capable of being identified according to what kinds of markers are present on the membrane. Currently, the most common cell surface markers are CD antigen, also known as CD molecules and clusters of differentiation. While CD molecules are very useful in defining leukocytes, they are not merely markers on the cell surface. While only a fraction of known CD molecules have been thoroughly characterized, most of them have an important function. Beyond the mere identification of cells, cell surface markers also hold the potential to aid in drug discovery and especially personalized medicine. With the ability to identify individual cells according to surface markers, scientists are beginning to make breakthroughs in the development of new drugs.

Market Dynamics

Increasing launches of new products, and mergers and acquisitions by key market players is expected to drive the global cell surface markers market growth. For instance, on January 13, 2021, Becton, Dickinson and Company, a U.S. based multinational medical technology company announced the commercial release of the BD AbSeq Immune Discovery Panel (IDP), a state-of-the-art, pre-titrated antibody-oligo based discovery tool designed to investigate 30 immune markers in a single experiment. The BD AbSeq IDP builds upon the advances of the BD AbSeq Assay, which analyzes protein expression at the single-cell level using next-generation sequencing. The BD AbSeq IDP offers researchers convenience, reliability and flexibility as both a multiomics-enabled and cost-efficient tool to aid in immune research and discovery. Also built upon BD antibody-oligo based technology, the BD AbSeq IDP consists of 30 different specificities targeting most major immune markers, conveniently grouped together in a single tube. The panel helps enable immune cell type identification.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell surface markers market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cell surface markers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell surface markers market

Detailed Segmentation:

Global Cell Surface Markers Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
Flow Cytometers
Hematology Analyzers
Reagents and Kits
Global Cell Surface Markers Market, By Application (Revenue, USD Bn, 2021 - 2033)
Disease Diagnosis and identification
Research/Drug Discovery
Global Cell Surface Markers Market, By (Revenue, USD Bn, 2021 - 2033)Region:
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East:
- GCC
- Israel
- Rest of Middle East
Africa
- Central Africa
- South Africa
- North Africa
Company Profiles
Abbott Laboratories, Inc.
Beckman Coulter, Inc.
BD Biosciences
Bio-Rad Laboratories, Inc.
Grifols SA
Immucor, Inc.
Janssen Diagnostics, Inc.
Nihon Kohden Corporation
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Sysmex Corporation
Thermo Fisher Scientific, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Cell Surface Markers Market, By Product Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Flow Cytometers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Hematology Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Cell Surface Markers Market, By Application, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Disease Diagnosis & Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Research/Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Cell Surface Markers Market, By Region, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Abbott Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BD Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Grifols SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Immucor, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Janssen Diagnostics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nihon Kohden Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Siemens Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies